Publication:
Modeling the activity of furin inhibitors using artificial neural network

dc.contributor.authorApilak Worachartcheewanen_US
dc.contributor.authorChanin Nantasenamaten_US
dc.contributor.authorThanakorn Naennaen_US
dc.contributor.authorChartchalerm Isarankura-Na-Ayudhyaen_US
dc.contributor.authorVirapong Prachayasittikulen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-09-13T06:32:12Z
dc.date.available2018-09-13T06:32:12Z
dc.date.issued2009-04-01en_US
dc.description.abstractQuantitative structure-activity relationship (QSAR) models were constructed for predicting the inhibition of furin-dependent processing of anthrax protective antigen of substituted guanidinylated aryl 2,5-dideoxystreptamines. Molecular descriptors calculated by E-Dragon and RECON were subjected to variable reduction using the Unsupervised Forward Selection (UFS) algorithm. The variables were then used as input for QSAR model generation using partial least squares and back-propagation neural network. Prediction was performed via a two-step approach: (i) perform classification to determine whether the molecule is active or inactive, (ii) develop a QSAR regression model of active molecules. Both classification and regression models yielded good results with RECON providing higher accuracy than that of E-DRAGON descriptors. The performance of the regression model using E-Dragon and RECON descriptors provided a correlation coefficient of 0.807 and 0.923 and root mean square error of 0.666 and 0.304, respectively. Interestingly, it was observed that appropriate representations of the protonation states of the molecules were crucial for good prediction performance, which coincides with the fact that the inhibitors interact with furin via electrostatic forces. The results provide good prospect of using the proposed QSAR models for the rational design of novel therapeutic furin inhibitors toward anthrax and furin-dependent diseases. © 2008 Elsevier Masson SAS. All rights reserved.en_US
dc.identifier.citationEuropean Journal of Medicinal Chemistry. Vol.44, No.4 (2009), 1664-1673en_US
dc.identifier.doi10.1016/j.ejmech.2008.09.028en_US
dc.identifier.issn17683254en_US
dc.identifier.issn02235234en_US
dc.identifier.other2-s2.0-61349110709en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/27430
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=61349110709&origin=inwarden_US
dc.subjectChemistryen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleModeling the activity of furin inhibitors using artificial neural networken_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=61349110709&origin=inwarden_US

Files

Collections